Acadia Healthcare (ACHC) Form 3: Executive Equity Ownership & Option Details
Rhea-AI Filing Summary
Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 3 showing an executive's direct share ownership and time‑based option grants, not a material change to capital structure.
The filing documents that the Interim CFO directly owns 30,661 common shares and holds options for 4,825 shares with specified exercise prices and long‑dated expirations. Vesting schedules are time‑based and spread across 2026–2028, indicating retention incentives rather than immediate dilution. This is a standard insider disclosure under Section 16.
TL;DR: Disclosure reflects executive compensation design with multi‑year vesting, aligning management with shareholder timelines.
The reported grants include multiple staggered vesting tranches (some vesting over two or three years), which suggests the company is using time‑based equity to retain executive leadership. All holdings are reported as direct, and no indirect holdings or related‑party arrangements are disclosed. The filing contains the required Power of Attorney remark for signature execution.